Kirkstall Quasi Vivo cell culture system

Wednesday, 14 February, 2018 | Supplied by: Capsugel Australia Pty Ltd


A common issue faced by drug discovery scientists who use conventional in vitro culture systems is their poor translatability to humans. To address this problem, Kirkstall’s Quasi Vivo system consists of interconnected cell-culture chambers and a peristaltic pump to create a continuous flow of media over cells. As a result, cultures are exposed to more physiologically relevant conditions, helping researchers improve the predictive value of in vitro experiments.

The system is available with three different culture chambers (QV500, QV600 and QV900) to support a wide range of applications, including submerged cell culture, co-culture and modelling of air-liquid and liquid-liquid interfaces. Not only is the system easy to set up, it also enables close monitoring of variables during an experiment. Furthermore, the large scale and user configurability of the system allow assays to be performed that are not possible using microfluidic systems.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Lonza 4D-Nucleofector LV Unit PRO electroporation unit

Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...

Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)

The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...

Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms

The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd